Bayer at BioTechX Europe 2026

Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website

Bayer takes part in 20 sessions at BioTechX Europe 2026 in Basel. Its sessions centre on AI for drug research and regulatory work, from using large language models to find drug targets to drafting regulatory documents. Distinctive topics include AI agents that analyse images of stained cells from drug screens and a knowledge graph that tracks why past projects were stopped.

OrganizationBioTechX Europe 2026 Attendance
Bayer
Leverkusen, Germany
Chair
Tue Oct 6
11:40
Chair's remarks
AI in Clinical Trials
Talk
Tue Oct 6
12:25
Chair
Tue Oct 6
15:25
Chair's remarks
Large Language models
Talk
Tue Oct 6
15:30
Building an open scientific RWD platform
Real World Data and Evidence · with Menarini
Talk
Tue Oct 6
15:30
Building the AI-Assisted Regulatory Document Ecosystem
How a set of AI tools helps teams plan applications to regulators, write and check the documents, and answer regulators' follow-up questions.
Talk
Tue Oct 6
16:00
CIME (Cheminformatics Model Explorer): Integrating Machine Learning into an Interactive Human in the Loop Workflow
Cheminformatics
Talk
Tue Oct 6
16:10
AI-Powered Regulatory Writing I: From Blank Page to First Draft
How AI can turn scattered source material into first drafts of documents for drug regulators while human experts stay in charge.
Talk
Tue Oct 6
16:50
Panel
Tue Oct 6
17:25
Autonomous R&D: Transforming Data and Regulatory Complexity into a Strategic Decision Advantage
Digital Transformation · with Servier, Wiley, Roche
Panel
Tue Oct 6
17:25
Gaining a competitive advantage in drug discovery through linked, multi-dimensional data at scale ​
What it takes to build large, well-labeled genome and cell datasets for AI drug discovery, and to link different datasets together.
with Illumina, Novo Nordisk, Sanofi
Chair
Wed Oct 7
11:40
Chair's remarks
AI in Drug Discovery and Development
Talk
Wed Oct 7
11:45
From Data to Answers: Exploring Agent-Driven Discovery in Cell Painting Screens
AI in Drug Discovery and Development
Talk
Wed Oct 7
12:25
Strategic view on digital innovation in clinical development
Clinical Technology & Innovation
Chair
Wed Oct 7
15:25
Chair's remarks
Digital Health
Talk
Wed Oct 7
15:30
Target discovery using LLM
Large Language models
Talk
Wed Oct 7
16:10
Clinical trials feasibility suite
AI in Clinical Trials
Panel
Wed Oct 7
17:25
Bridging AI and Open Source: Advancing Data Science for Clinical Quality by IMPALA consortium
Digital Transformation · with Roche, Boehringer Ingelheim, MSD
Panel
Wed Oct 7
17:25
Your LLM is Monolingual – Your BioTech Company Isn’t. Now What?
What goes wrong when biotech teams working in many languages use AI models trained mostly on English, and what they can do.
with University of Zurich, University of Alabama at Birmingham
Talk
Thu Oct 8
12:10
Agentic Competitive Intelligence: How to Walk the Trust–Coverage–Speed Tightrope and Stay Upright
Lessons from running an AI assistant that tracks competitors, and how to balance being trustworthy, thorough and fast enough for business decisions.
Keynote
Thu Oct 8
13:20
Women in Leadership Keynote Panel
Keynotes · with Pistoia Alliance, Our Future Health, Ignota Labs +1 more

Explore the full BioTechX Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full BioTechX Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Bayer

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction